Hepatorenal syndrome

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.12, Iss.9, 2011-06, pp. : 1405-1417

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The natural history and management of hepatorenal disorders: from pre-ascites to hepatorenal syndrome

By Blendis Laurie Wong Florence

Clinical Medicine, Vol. 3, Iss. 2, 2003-03 ,pp. : 154-159

Royal College Of Physicians

Access to resources Recommend Favorite

Vasoconstrictor Therapy for Hepatorenal Syndrome in Liver Cirrhosis

Current Pharmaceutical Design, Vol. 12, Iss. 35, 2006-12 ,pp. : 4637-4647

Bentham Science Publishers

Access to resources Recommend Favorite

Terlipressin in cirrhosis and type 1 hepatorenal syndrome

Inpharma, Vol. 1, Iss. 1341, 2002-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Sulfadiazine: Hepatotoxicity and hepatorenal syndrome: case report

Reactions Weekly, Vol. 1, Iss. 1378, 2011-01 ,pp. : 32-32

Adis International

Access to resources Recommend Favorite

Intrahepatic adenosine-mediated activation of hepatorenal reflex is via A₁ receptors in rats

By Ming Zhi Lautt W. W.

Canadian Journal of Physiology and Pharmacology, Vol. 84, Iss. 11, 2006-11 ,pp. : 1177-1184

NRC Research Press

Access to resources Recommend Favorite